Bicycle Therapeutics PLC (BCYC)
24.58
-0.11
(-0.45%)
USD |
NASDAQ |
May 03, 16:00
24.61
+0.03
(+0.12%)
After-Hours: 20:00
Bicycle Therapeutics Price to Book Value: 2.510 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 2.510 |
| May 02, 2024 | 2.521 |
| May 01, 2024 | 2.471 |
| April 30, 2024 | 2.395 |
| April 29, 2024 | 2.391 |
| April 26, 2024 | 2.321 |
| April 25, 2024 | 2.300 |
| April 24, 2024 | 2.315 |
| April 23, 2024 | 2.316 |
| April 22, 2024 | 2.305 |
| April 19, 2024 | 2.395 |
| April 18, 2024 | 2.501 |
| April 17, 2024 | 2.228 |
| April 16, 2024 | 2.240 |
| April 15, 2024 | 2.228 |
| April 12, 2024 | 2.277 |
| April 11, 2024 | 2.298 |
| April 10, 2024 | 2.348 |
| April 09, 2024 | 2.356 |
| April 08, 2024 | 2.345 |
| April 05, 2024 | 2.321 |
| April 04, 2024 | 2.309 |
| April 03, 2024 | 2.382 |
| April 02, 2024 | 2.423 |
| April 01, 2024 | 2.476 |
| Date | Value |
|---|---|
| March 28, 2024 | 2.543 |
| March 27, 2024 | 2.507 |
| March 26, 2024 | 2.505 |
| March 25, 2024 | 2.597 |
| March 22, 2024 | 2.603 |
| March 21, 2024 | 2.640 |
| March 20, 2024 | 2.615 |
| March 19, 2024 | 2.507 |
| March 18, 2024 | 2.463 |
| March 15, 2024 | 2.426 |
| March 14, 2024 | 2.343 |
| March 13, 2024 | 2.609 |
| March 12, 2024 | 2.557 |
| March 11, 2024 | 2.417 |
| March 08, 2024 | 2.589 |
| March 07, 2024 | 2.588 |
| March 06, 2024 | 2.516 |
| March 05, 2024 | 2.518 |
| March 04, 2024 | 2.496 |
| March 01, 2024 | 2.627 |
| February 29, 2024 | 2.562 |
| February 28, 2024 | 2.653 |
| February 27, 2024 | 2.665 |
| February 26, 2024 | 2.610 |
| February 23, 2024 | 2.516 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.153
Minimum
Aug 28 2019
10.52
Maximum
Nov 15 2021
3.553
Average
3.133
Median
Price to Book Value Benchmarks
| Biodexa Pharmaceuticals Plc | 0.8683 |
| NuCana PLC | 0.446 |
| TC BioPharm (Holdings) PLC | 1.364 |
| Adaptimmune Therapeutics PLC | 7.434 |
| Autolus Therapeutics PLC | 9.995 |
Price to Book Value Related Metrics
| PS Ratio | 32.41 |
| PEG Ratio | -0.1369 |
| Price | 24.58 |
| Earnings Yield | -20.87% |
| Market Cap | 931.10M |
| PEGY Ratio | -0.1369 |